T0	KEYPHRASE-NOTYPES 0 8	Patients
T1	KEYPHRASE-NOTYPES 25 30	areas
T2	KEYPHRASE-NOTYPES 37 49	Lyme disease
T3	KEYPHRASE-NOTYPES 77 82	years
T4	KEYPHRASE-NOTYPES 86 89	age
T5	KEYPHRASE-NOTYPES 131 147	Lyme borreliosis
T6	KEYPHRASE-NOTYPES 166 176	enrollment
T7	KEYPHRASE-NOTYPES 185 194	openlabel
T8	KEYPHRASE-NOTYPES 220 237	multicenter study
T9	KEYPHRASE-NOTYPES 243 248	study
T10	KEYPHRASE-NOTYPES 271 274	May
T11	KEYPHRASE-NOTYPES 284 288	June
T12	KEYPHRASE-NOTYPES 295 311	Erythema migrans
T13	KEYPHRASE-NOTYPES 347 371	erythematous skin lesion
T14	KEYPHRASE-NOTYPES 383 385	cm
T15	KEYPHRASE-NOTYPES 389 397	diameter
T16	KEYPHRASE-NOTYPES 416 427	study entry
T17	KEYPHRASE-NOTYPES 442 449	disease
T18	KEYPHRASE-NOTYPES 480 487	patient
T19	KEYPHRASE-NOTYPES 511 520	following
T20	KEYPHRASE-NOTYPES 536 559	erythema migrans lesion
T21	KEYPHRASE-NOTYPES 561 569	carditis
T22	KEYPHRASE-NOTYPES 584 595	heart block
T23	KEYPHRASE-NOTYPES 597 621	neurologic abnormalities
T24	KEYPHRASE-NOTYPES 623 650	seventh-cranial-nerve palsy
T25	KEYPHRASE-NOTYPES 654 665	radiculitis
T26	KEYPHRASE-NOTYPES 685 701	months duration
T27	KEYPHRASE-NOTYPES 708 735	acute large-joint arthritis
T28	KEYPHRASE-NOTYPES 737 740	nWe
T29	KEYPHRASE-NOTYPES 762 775	nursing women
T30	KEYPHRASE-NOTYPES 780 788	patients
T31	KEYPHRASE-NOTYPES 794 802	evidence
T32	KEYPHRASE-NOTYPES 806 814	syphilis
T33	KEYPHRASE-NOTYPES 816 826	meningitis
T34	KEYPHRASE-NOTYPES 831 856	collagen vascular disease
T35	KEYPHRASE-NOTYPES 858 874	current symptoms
T36	KEYPHRASE-NOTYPES 878 890	Lyme disease
T37	KEYPHRASE-NOTYPES 930 939	treatment
T38	KEYPHRASE-NOTYPES 962 969	disease
T39	KEYPHRASE-NOTYPES 989 999	evaluation
T40	KEYPHRASE-NOTYPES 1007 1015	response
T41	KEYPHRASE-NOTYPES 1019 1028	treatment
T42	KEYPHRASE-NOTYPES 1030 1049	gallbladder disease
T43	KEYPHRASE-NOTYPES 1054 1070	hypersensitivity
T44	KEYPHRASE-NOTYPES 1074 1085	ceftriaxone
T45	KEYPHRASE-NOTYPES 1089 1100	doxycycline
T46	KEYPHRASE-NOTYPES 1102 1110	Patients
T47	KEYPHRASE-NOTYPES 1124 1144	antimicrobial agents
T48	KEYPHRASE-NOTYPES 1158 1170	Lyme disease
T49	KEYPHRASE-NOTYPES 1181 1186	hours
T50	KEYPHRASE-NOTYPES 1194 1205	study entry
T51	KEYPHRASE-NOTYPES 1225 1249	investigational compound
T52	KEYPHRASE-NOTYPES 1261 1266	weeks
T53	KEYPHRASE-NOTYPES 1274 1285	study entry
T54	KEYPHRASE-NOTYPES 1314 1322	patients
T55	KEYPHRASE-NOTYPES 1328 1338	meningitis
T56	KEYPHRASE-NOTYPES 1342 1354	encephalitis
